Alligator Bioscience AB (FRA:7AL0) Change In Inventory : €0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Alligator Bioscience AB Change In Inventory?

Alligator Bioscience AB's change in inventory for the quarter that ended in Mar. 2025 was €0.00 Mil. It means Alligator Bioscience AB's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Alligator Bioscience AB's change in inventory for the fiscal year that ended in Dec. 2024 was €0.00 Mil. It means Alligator Bioscience AB's inventory stayed the same from Dec. 2023 to Dec. 2024 .

Alligator Bioscience AB's Total Inventories for the quarter that ended in Mar. 2025 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Alligator Bioscience AB Change In Inventory Historical Data

The historical data trend for Alligator Bioscience AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB Change In Inventory Chart

Alligator Bioscience AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Inventory

Get a 7-Day Free Trial

Alligator Bioscience AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Alligator Bioscience AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Alligator Bioscience AB (FRA:7AL0) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Alligator Bioscience AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Alligator Bioscience AB's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Alligator Bioscience AB's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Alligator Bioscience AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Alligator Bioscience AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (FRA:7AL0) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

ATORX:Sweden 0RK9:UK 7AL0:Germany

Address

Medicon Village, Scheeletorget 1, Lund, SWE, 223 81

Website

https://www.alligatorbioscience.se

Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. Its drug candidate mitazalimab, is currently in preparation for Phase 3 development, and has previously presented unprecedented survival data at 18-months follow up in first-line metastatic pancreatic cancer patients in the Phase 2 trial OPTIMIZE-1.

Alligator Bioscience AB Headlines

No Headlines